Kairos Pharma, Ltd. Common Stock (KAPA)

In today's session, these stocks are experiencing unusual volume.

The regular session of the US market on Tuesday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.

Kairos Pharma reported strong safety results from a Phase 2 trial of ENV-105 in mCRPC, with no serious toxicities seen in the first 10 patients.

Discover the most active stocks in Tuesday's session. Stay informed about the stocks that are generating the most trading volume!

Wondering how the US markets performed in the middle of the day on Tuesday? Discover the movers and shakers of today's session in our comprehensive analysis.

Let's have a look at what is happening on the US markets on Tuesday. Below you can find the gap up and gap down stocks in today's session.

Discover the top movers in Tuesday's pre-market session and stay informed about market dynamics.

Volume analysis on 2025-06-10: stocks with an unusual volume in today's session.

As the regular session of the US market concludes on Monday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.

Let's have a look at what is happening on the US markets on Thursday. Below you can find the stocks with an unusual volume in today's session.

Discover the top movers in Thursday's pre-market session and stay informed about market dynamics.